SMMT241018P16000
- 0.03
- 0.000.00%
Summit Therapeutics Newsroom
Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics Vs. Summit Therapeutics
3 Things You Need to Know If You Buy Summit Therapeutics Stock Today
(SMMT) - Analyzing Summit Therapeutics's Short Interest
Summit Therapeutics Inc (SMMT) Q2 2024 Earnings Call Highlights: Strategic Advances and ...
Coinbase, Nike And Moderna Are Among Top 11 Large Cap Losers Last Week (Sept 30-Oct 4): Are The Others In Your Portfolio?
Summit Therapeutics Inc. (SMMT): Hedge Funds Are Bullish On This NASDAQ Stock Right Now
Is Summit Therapeutics a Millionaire Maker?
Summit Therapeutics Completes Enrollment in Phase III HARMONi Trial
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sector Update: Health Care
Stocks Making the Biggest Moves Premarket: Spirit Airlines, Summit Therapeutics, Rivian and More
Stifel Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $40
S&P 500 Futures Rise In Premarket Trading; Summit Therapeutics, Axalta Coating Systems Lead
H.C. Wainwright Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $45
HC Wainwright & Co. Reiterates Buy on Summit Therapeutics, Maintains $45 Price Target
Buy Rating Affirmed for Summit Therapeutics Amid Promising Clinical Trials and Regulatory Progress
Summit Stock Jumps as FDA Grants Fast Track Tag for Lung Cancer Therapy
Biggest Stock Movers Friday: SAVE and SMMT
Update: Summit Therapeutics Closes Phase 3 Lung Cancer Study Enrollment, Gets FDA Fast Track; Shares up Premarket
US MOVERS&SHAKERS Sep 30-Oct 04, 2024